Arisan Therapeutics Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Arisan Therapeutics Inc.
Quantité totale PI 14
Rang # Quantité totale PI 110 358
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 085

Brevets

Marques

6 0
1 0
7 0
0
 
Dernier brevet 2025 - Crystalline forms of an imidazop...
Premier brevet 2016 - Compounds for the treatment of a...

Derniers inventions, produits et services

2024 Invention Crystalline forms of an imidazopyridine derivative. Polymorphic forms A, B, C, D, E, and F of Com...
2023 Invention Heterocyclic compounds as therapeutic agents. The invention relates to compounds of structural f...
2022 Invention Heterocyclic compounds for the treatment of arenavirus infection. The invention relates to compo...
2021 Invention Heterocyclic compounds as therapeutic agents. The invention relates to compounds of structural fo...
Invention Adamantane amides and thioamides for the treatment of ebolavirus infection. Compounds of Structu...
Invention Adamantane amides and thioamides for the treatment of ebolavirus infection. Compounds of Structur...
2019 Invention Compounds for the treatment of arenavirus infection. Compounds as exemplified by compound A are ...
Invention Compounds for the treatment of arenavirus infection. Compounds as exemplified by compound A are u...
2018 Invention Adamantane derivatives for the treatment of filovirus infection. 3, X and Y are defined in the sp...
Invention Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection. The compo...
Invention Enantiomerically pure adamantane derivatives for the treatment of filovirus infection. The compou...
2017 Invention Heterocyclic compounds for the treatment of arenavirus. The invention relates to compounds of str...
Invention Heterocyclic compounds for the treatment of arenavirus infection. The invention relates to compou...
2016 Invention Compounds for the treatment of arenavirus infection. The present invention relates to the use of ...